Trials / Completed
CompletedNCT01002937
Novel Prognostic Markers in Renal Cancer
Novel Prognostic Markers in Renal Cancer: a Protocol for the Analysis of Paraffin Embedded Tumour Samples
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 182 (actual)
- Sponsor
- Royal Marsden NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this project is to analyze tumour tissue from a group of subjects with renal cell carcinoma, who have been treated at the Royal Marsden Hospital.
Detailed description
Renal cancers have different clinical outcomes. The principal research objective is to study tumour tissue from renal cancer patients and try and understand why some cancers progress more rapidly than others. Further, another key aim of this study is to try and understand why some patients respond to treatment and others do not.
Conditions
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2014-12-17
- Completion
- 2014-12-17
- First posted
- 2009-10-28
- Last updated
- 2024-06-18
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01002937. Inclusion in this directory is not an endorsement.